Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox for Chronic Wound Pain
NCT05426161Phase 4Completed
- Sponsor
- Bispebjerg and Frederiksberg Hospital
- Start
- Feb 2023
- Primary completion
- Apr 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of botulinum toxin type A in neuropathic pain, sponsored by Bispebjerg and Frederiksberg Hospital. Started Feb 2023; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT05426161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05426161.